BridgeBio Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBIO and other ETFs, options, and stocks.

About BBIO

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. 

CEO
Neil Kumar
CEONeil Kumar
Employees
839
Employees839
Headquarters
Palo Alto, California
HeadquartersPalo Alto, California
Founded
2015
Founded2015
Employees
839
Employees839

BBIO Key Statistics

Market cap
15.67B
Market cap15.67B
Price-Earnings ratio
-22.38
Price-Earnings ratio-22.38
Dividend yield
Dividend yield
Average volume
2.21M
Average volume2.21M
High today
$80.23
High today$80.23
Low today
$78.13
Low today$78.13
Open price
$79.15
Open price$79.15
Volume
1.65M
Volume1.65M
52 Week high
$93.42
52 Week high$93.42
52 Week low
$46.81
52 Week low$46.81

Stock Snapshot

BridgeBio Pharma(BBIO) stock is priced at $80.16, giving the company a market capitalization of 15.67B. It carries a P/E multiple of -22.38.

During the trading session on 2026-08-17, BridgeBio Pharma(BBIO) shares reached a daily high of $80.23 and a low of $78.13. At a current price of $80.16, the stock is +2.6% higher than the low and still -0.1% under the high.

Trading activity shows a volume of 1.65M, compared to an average daily volume of 2.21M.

The stock's 52-week range extends from a low of $46.81 to a high of $93.42.

The stock's 52-week range extends from a low of $46.81 to a high of $93.42.

BBIO News

TipRanks 5h
BridgeBio Pharma announces major secondary share offering

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

Simply Wall St 1d
Is BridgeBio Pharma Priced For Perfection Or Fair Value?

BridgeBio Pharma has delivered a strong share price run over the past three years, yet the broader valuation checks now point to a stock that looks closer to fa...

Is BridgeBio Pharma Priced For Perfection Or Fair Value?
The Motley Fool 3d
BridgeBio Stock Has Soared 29% in Just 3 Months. Here's Why Wall Street Thinks It Could Go Even Higher. - The Motley Fool

...

BridgeBio Stock Has Soared 29% in Just 3 Months. Here's Why Wall Street Thinks It Could Go Even Higher. - The Motley Fool

Analyst ratings

87%

of 23 ratings
Buy
87%
Hold
13%
Sell
0%

More BBIO News

TipRanks 6d
BridgeBio’s New Series A Preferred Stock Heightens Capital Structure Risk and Dilution Threat for Common Shareholders

Bridgebio Pharma (BBIO) has disclosed a new risk, in the Share Price & Shareholder Rights category. Unlock powerful investing tools with TipRanks Premium to ma...

People also own

Based on the portfolios of people who own BBIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.